Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ares Life Sciences

Ares Life Sciences?uq=w9if130k
PE INVESTOR TYPE
Inactive STATUS
29 INVESTMENTS
8 EXITS
Description

Ares Life Sciences was a healthcare-focused investment firm that focuses on investment in companies operating in the life science, pharmaceutical, drug, biotechnology, therapeutic, medical diagnostic, healthcare service and medical technology sectors. It was based in Jersey, England.

Investor Status
Out of Business
Year Founded
2008
Primary Investor Type
PE/Buyout
Other Investor Types
Growth/Expansion
Venture Capital
Primary Office
  • 28-30 The Parade
  • St. Helier
  • Jersey JE1 1ZZ
  • Jersey

Ares Life Sciences Investments (29)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
000000000000 08-Sep-2015 0000000000 Drug Discovery Generating Revenue 0000000 0000000000
000000000 0000000 03-Mar-2015 0000000000 Clinics/Outpatient Services Generating Revenue 0000000 0000000000
000 000000 00000 14-Jul-2014 000000000 00 000.00 Diagnostic Equipment Profitable 0000000 0000000000
00000000 000000 00 04-Jun-2014 0000000000 Other Healthcare Services Generating Revenue 0000000 0000000000
Greer Laboratories 30-Apr-2013 Buyout/LBO Laboratory Services (Healthcare) Profitable 0000000 0000000000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ares Life Sciences’s full profile, request a free trial.

Ares Life Sciences Exits (8)

Company Name Exit Date Exit Type Exit Size Status Buyers
000 000000 00000 19-Apr-2018 0000000000 00000 Completed
  • 6 buyers
0000000 09-Oct-2014 0000000000 00.000 Completed
  • 00000000 0000000 (
00000000 0000 06-Jun-2014 000000000000000000 Completed
  • 00000000
00000000 000000 06-Jun-2014 000000000000000000 Completed
  • 00000000
Euromedic (Czech Lab Division) 21-Oct-2013 Buyout/LBO Completed
  • 2 buyers
To view this investor’s complete exits history, request access »